The Oncology Institute, Inc.

NasdaqCM:TOI

Market Cap

USD 272.98 M

Share Price

USD 2.97

Avg Daily Volume

1,814,421

Change (1 day)

-7.48%

Change (1 year)

Change (YTD)

314.75%

The Oncology Institute, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -13.22%

The Oncology Institute, Inc. EBIT Margin is -13.22% for the Trailing 12 Months (TTM) ending March 31, 2025, a -33.08% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • The Oncology Institute, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -19.75%, a 32.21% change year over year.
  • The Oncology Institute, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -14.94%, a -5.30% change year over year.
  • The Oncology Institute, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -15.77%, a 387.51% change year over year.
  • The Oncology Institute, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -3.24%.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin